New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 31, 2014
09:27 EDTALGNAlign Technology price target raised to $66 from $56 at Roth Capital
Roth Capital increased its price target on Align after the company reported stronger than expected Q4 results. The firm expects the company to generate strong results in 2014, and it keeps a Buy rating on the stock.
News For ALGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
08:57 EDTALGNClearCorrect says granted request for fourth Align patent reexam, Bloomberg says
A ClearCorrect spokeswoman stated to Bloomberg via e-mail that the company was granted a fourth request for reexamination of an Align Technology patent yesterday by the USPTO, the news service reported. An Align Technology spokeswoman remarked that the grant for fourth reexamination was “not unexpected” and said the patent was previously found to be valid during an ITC investigation, the report added.
June 18, 2015
07:13 EDTALGNMorgan Stanley says to buy Align Technology on weakness
Subscribe for More Information
07:01 EDTALGNAlign Technology selloff a buying opportunity, say William Blair
Subscribe for More Information
05:41 EDTALGNSouthwest downgraded to Underweight from Overweight at Barclays
Barclays analyst David Fintzen downgraded Southwest (LUV) two notches to Underweight from Overweight saying the company has moved from a margin expansion story to an "average" big four airline trading at a premium valuation. Fintzen expects Southwest's growth to normalize in 2016 and cut his price target for shares to $39 from $50. The stock closed yesterday down 7c to $33.84. The analyst coupled the downgrade with an upgrade of Align Technology (ALGN) to Equal Weight. He remains bullish on airlines, with Spirit Airlines (SAVE) remaining his top pick, followed by Delta Air Lines (DAL), American Airlines (AAL) and United Continental (UAL). Fintzen sees 50% average upside in those four names.
June 17, 2015
16:52 EDTALGNAlign Technology provides statements regarding USPTO findings
Subscribe for More Information
13:11 EDTALGNAlign Technology weakness on patent concerns overdone, says Goldman
Subscribe for More Information
11:46 EDTALGNAlign drops after USPTO grants ClearCorrect request for patent review
ClearCorrect, a manufacturer of clear aligners, announced that the United States Patent and Trademark Office has granted its request for reexamination of three U.S. Patents assigned to Align Technology (ALGN). It stated in a press release, "ClearCorrect's evidence of unpatentability has been accepted by the USPTO across all challenged patents. A formal rejection of the claims of the '325 patent has been issued. Align must respond to this notice within two months' time if reversal of the USPTO's determination is to be pursued. The USPTO is set to issue formal rejections in the '487 and '880 patents in the weeks ahead based upon some of the same evidence." ClearCorrect has filed four reexamination requests concerning patents held by Align. Acceptance of the fourth request is expected in due course, the company stated. Shares of Align are down $4.19 to $60.10 following the news.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use